Theratechnologies Inc

Theratechnologies Inc. is a biopharmaceutical company based in Saint-Laurent, Quebec, dedicated to the development and commercialization of innovative therapies, particularly for individuals living with HIV. The company currently markets two prescription products, Trogarzo and EGRIFTASV, in the United States, while also advancing a pipeline focused on specialized therapies in HIV and oncology.

With a commitment to addressing unmet medical needs, Theratechnologies is actively engaged in clinical trials and the development of novel formulations, including the F8 formulation of tesamorelin, which offers advantages over previous versions. The company aims to make a significant impact on patient lives through its innovative approaches and therapies.

Generated from the website